This is a time of awakening to the power and meaning of psychedelic substances in the human experience.
The laws and regulations regarding the use and possession of psilocybin mushrooms and other “entheogenic natural substances” are changing rapidly as they shed layers of stigmatization and gain greater acceptance in society. Since 2019, municipalities across the U.S. including Denver, Santa Cruz, Oakland, Ann Arbor, MI, Washington D.C. and Somerville, Massachusetts and others have passed local laws decriminalizing and/or limited resources to prosecute the use and possession of psychedelic substances.
In 2019, the U.S. Food and Drug Administration gave psilocybin mushrooms breakthrough therapy status for treating PTSD, anxiety and for assisting with end of life issues. This designation has helped catalyze greater levels of acceptance and an infusion of interest and research funding. One example is the Johns Hopkins Center for Psychedelic Consciousness and Research.
In November 2020, the State of Oregon passed into law is Psilocybin Services Act. Under this new law, the state will license providers who will be permitted to treat their patients under their supervision with psilocybin therapies to treat anxiety, depression PTSD and even substance abuse disorder.
June 2021 saw the passage in the California state Senate of SB 519, a bill that legalizes possession of psychedelics. Accordingly to some analysts, the bill stands a good chance of passing the House. If that happens, the bill would then proceed to the desk of California Governor Gavin Newsom. If passed, a list of psychedelics would be decriminalized in California — including LSD, psilocybin mushrooms, DMT and MDMA.
If you are called towards operating in the psychedelics legal space you need the advice of counsel that remains focused on this rapidly changing regulatory landscape. Jeffrey Kaloustian is a stellar choice and a natural fit as your attorney and advisor in the psychedelics law arena.
